TLT.v Message Board - Msg: 32415064

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TLT.v

TLT.V 0.160

+3.2%

10:16 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

3bar

To: 3bar who wrote (1426)	11/12/2019 2:55:14 PM
From: ogi	1 Recommendation of 1868

Nice to see it is not a paid for article. Short and sweet but does not miss much. Here is the actual magazine link. healthcareimc.com TLT behaving like some news on the horizon. Time to crawl out of the basement hopefully. OOOOPS !! I read " about us" which gave no indication the publication was there for company promotion. The TLT article is by TLT, glad they got it right :) All posts by Shushu Feng Public Relations/Investor Relations Coordinator for Theralase Technologies Inc Articles Canadian Clinical Stage Biopharmaceutical Company Advances New Cancer Treatment November 8, 2019 Shushu Feng A Toronto based clinical-stage biopharmaceutical company is quickly advancing on what may prove to be one of the safest and most effective cancer treatments ever developed. Theralase Technologies Inc. (“Theralase”) is conducting a pivotal Phase II clinical study, with a primary objective of efficacy, of a cutting-edge anti-cancer treatment that utilizes laser light activated anti-cancer … Continue reading Canadian Clinical Stage Biopharmaceutical Company Advances New Cancer Treatment ?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next